Glenmede Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,502
| Closed | -$591K | – | 1386 |
|
|
2023
Q2 | $591K | Hold |
6,502
| – | – | ﹤0.01% | 790 |
|
|
2023
Q1 | $591K | Buy |
+6,502
| New | +$591K | ﹤0.01% | 793 |
|
|
2020
Q4 | – | Sell |
-400
| Closed | -$38K | – | 2390 |
|
|
2020
Q3 | $38K | Sell |
400
-662
| -62% | -$62.9K | ﹤0.01% | 1410 |
|
|
2020
Q2 | $165K | Sell |
1,062
-673
| -39% | -$105K | ﹤0.01% | 1055 |
|
|
2020
Q1 | $354K | Hold |
1,735
| – | – | ﹤0.01% | 1003 |
|
|
2019
Q4 | $354K | Buy |
1,735
+1,266
| +270% | +$258K | ﹤0.01% | 1003 |
|
|
2019
Q3 | $37 | Buy |
469
+9
| +2% | +$1 | ﹤0.01% | 1801 |
|
|
2019
Q2 | $43 | Hold |
460
| – | – | ﹤0.01% | 1756 |
|
|
2019
Q1 | $39 | Buy |
+460
| New | +$39 | ﹤0.01% | 1800 |
|